Research shines light on early life factors that may increase risk of cardiovascular disease in women

Advanced research is casting light on possible early life factors – including poverty, physical or mental abuse – that may impact the rate of egg loss and increase the risk of cardiovascular disease in post-menopausal women.

Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on

January 31, 2024

Doccla Acquires OpenTeleHealth, Expanding in 12 Markets – M&A

What You Should Know: – London-based virtual ward technology provider Doccla today announced the acquisition of medically certified cloud-based platform OpenTeleHealth (OTH). – Founded in

August 18, 2023

Novo Nordisk sues unauthorized semaglutide compounders, tempers expectations for Wegovy’s global rollout

Novo Nordisk is striking back against illegal semaglutide compounders, filing an initial five lawsuits and preparing more in the coming days and weeks. The first

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.